Logo image of AMR

ALPHA METALLURGICAL RESOURCE (AMR) Stock Fundamental Analysis

NYSE:AMR - US0207641061 - Common Stock

144.94 USD
+0.36 (+0.25%)
Last: 8/26/2025, 8:14:52 PM
145 USD
+0.06 (+0.04%)
Pre-Market: 8/27/2025, 5:29:02 AM
Fundamental Rating

6

Overall AMR gets a fundamental rating of 6 out of 10. We evaluated AMR against 155 industry peers in the Metals & Mining industry. While AMR has a great health rating, its profitability is only average at the moment. AMR has a valuation in line with the averages, but it does not seem to be growing.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

AMR had negative earnings in the past year.
In the past year AMR had a positive cash flow from operations.
AMR had positive earnings in 4 of the past 5 years.
In the past 5 years AMR always reported a positive cash flow from operatings.
AMR Yearly Net Income VS EBIT VS OCF VS FCFAMR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

1.2 Ratios

AMR has a better Return On Assets (1.11%) than 60.65% of its industry peers.
AMR has a Return On Equity (1.65%) which is in line with its industry peers.
AMR has a Return On Invested Capital (1.87%) which is in line with its industry peers.
AMR had an Average Return On Invested Capital over the past 3 years of 39.19%. This is significantly above the industry average of 12.86%.
The 3 year average ROIC (39.19%) for AMR is well above the current ROIC(1.87%). The reason for the recent decline needs to be investigated.
Industry RankSector Rank
ROA 1.11%
ROE 1.65%
ROIC 1.87%
ROA(3y)33.45%
ROA(5y)17.86%
ROE(3y)52.85%
ROE(5y)-2.4%
ROIC(3y)39.19%
ROIC(5y)N/A
AMR Yearly ROA, ROE, ROICAMR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 100 -100 -200

1.3 Margins

The Profit Margin of AMR (1.01%) is better than 60.65% of its industry peers.
In the last couple of years the Profit Margin of AMR has declined.
With a Operating Margin value of 1.74%, AMR perfoms like the industry average, outperforming 49.68% of the companies in the same industry.
In the last couple of years the Operating Margin of AMR has grown nicely.
With a Gross Margin value of 12.09%, AMR perfoms like the industry average, outperforming 45.81% of the companies in the same industry.
AMR's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 1.74%
PM (TTM) 1.01%
GM 12.09%
OM growth 3Y-22.8%
OM growth 5Y51.85%
PM growth 3Y-20.84%
PM growth 5YN/A
GM growth 3Y-12.72%
GM growth 5Y0.52%
AMR Yearly Profit, Operating, Gross MarginsAMR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 20 -20 40

9

2. Health

2.1 Basic Checks

The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so AMR is creating value.
Compared to 1 year ago, AMR has more shares outstanding
AMR has less shares outstanding than it did 5 years ago.
Compared to 1 year ago, AMR has an improved debt to assets ratio.
AMR Yearly Shares OutstandingAMR Yearly Shares OutstandingYearly Shares Outstanding 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M
AMR Yearly Total Debt VS Total AssetsAMR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 500M 1B 1.5B 2B 2.5B

2.2 Solvency

AMR has an Altman-Z score of 4.21. This indicates that AMR is financially healthy and has little risk of bankruptcy at the moment.
Looking at the Altman-Z score, with a value of 4.21, AMR is in the better half of the industry, outperforming 69.03% of the companies in the same industry.
AMR has a debt to FCF ratio of 0.02. This is a very positive value and a sign of high solvency as it would only need 0.02 years to pay back of all of its debts.
AMR's Debt to FCF ratio of 0.02 is amongst the best of the industry. AMR outperforms 95.48% of its industry peers.
AMR has a Debt/Equity ratio of 0.00. This is a healthy value indicating a solid balance between debt and equity.
The Debt to Equity ratio of AMR (0.00) is better than 80.65% of its industry peers.
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.02
Altman-Z 4.21
ROIC/WACC0.18
WACC10.14%
AMR Yearly LT Debt VS Equity VS FCFAMR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B 1.5B

2.3 Liquidity

AMR has a Current Ratio of 3.87. This indicates that AMR is financially healthy and has no problem in meeting its short term obligations.
With a decent Current ratio value of 3.87, AMR is doing good in the industry, outperforming 74.19% of the companies in the same industry.
A Quick Ratio of 3.14 indicates that AMR has no problem at all paying its short term obligations.
AMR has a Quick ratio of 3.14. This is in the better half of the industry: AMR outperforms 71.61% of its industry peers.
Industry RankSector Rank
Current Ratio 3.87
Quick Ratio 3.14
AMR Yearly Current Assets VS Current LiabilitesAMR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M 800M 1B

2

3. Growth

3.1 Past

AMR shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -108.43%.
The Earnings Per Share has been decreasing by -1.85% on average over the past years.
The Revenue for AMR has decreased by -14.81% in the past year. This is quite bad
AMR shows quite a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 8.12% yearly.
EPS 1Y (TTM)-108.43%
EPS 3Y-1.85%
EPS 5YN/A
EPS Q2Q%-108.46%
Revenue 1Y (TTM)-14.81%
Revenue growth 3Y9.4%
Revenue growth 5Y8.12%
Sales Q2Q%-31.56%

3.2 Future

Based on estimates for the next years, AMR will show a decrease in Earnings Per Share. The EPS will decrease by -1.55% on average per year.
The Revenue is expected to decrease by -1.61% on average over the next years.
EPS Next Y-130.1%
EPS Next 2Y20.22%
EPS Next 3Y-1.42%
EPS Next 5Y-1.55%
Revenue Next Year-24.17%
Revenue Next 2Y-3.7%
Revenue Next 3Y-2.95%
Revenue Next 5Y-1.61%

3.3 Evolution

When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is stable.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AMR Yearly Revenue VS EstimatesAMR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2014 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 1B 2B 3B 4B
AMR Yearly EPS VS EstimatesAMR Yearly EPS VS EstimatesYearly EPS VS Estimates 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 2028 2029 2030 2031 0 20 -20 40 60 80

5

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for AMR. In the last year negative earnings were reported.
A Price/Forward Earnings ratio of 7.06 indicates a rather cheap valuation of AMR.
Based on the Price/Forward Earnings ratio, AMR is valued cheaply inside the industry as 92.26% of the companies are valued more expensively.
AMR's Price/Forward Earnings ratio indicates a rather cheap valuation when compared to the S&P500 average which is at 22.67.
Industry RankSector Rank
PE N/A
Fwd PE 7.06
AMR Price Earnings VS Forward Price EarningsAMR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 0 20 -20 -40

4.2 Price Multiples

AMR's Enterprise Value to EBITDA ratio is rather cheap when compared to the industry. AMR is cheaper than 85.81% of the companies in the same industry.
93.55% of the companies in the same industry are more expensive than AMR, based on the Price/Free Cash Flow ratio.
Industry RankSector Rank
P/FCF 8.14
EV/EBITDA 6.54
AMR Per share dataAMR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 0 50 100 150 200

4.3 Compensation for Growth

The decent profitability rating of AMR may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y20.22%
EPS Next 3Y-1.42%

2

5. Dividend

5.1 Amount

With a yearly dividend of 0.73%, AMR is not a good candidate for dividend investing.
AMR's Dividend Yield is a higher than the industry average which is at 2.60.
With a Dividend Yield of 0.73, AMR pays less dividend than the S&P500 average, which is at 2.34.
Industry RankSector Rank
Dividend Yield 0.73%

5.2 History

AMR does not have a reliable dividend history as it only pays dividend since a couple or years.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
AMR Yearly Dividends per shareAMR Yearly Dividends per shareYearly Dividends per share 2022 2023 2 4 6

5.3 Sustainability

1.85% of the earnings are spent on dividend by AMR. This is a low number and sustainable payout ratio.
DP1.85%
EPS Next 2Y20.22%
EPS Next 3Y-1.42%
AMR Yearly Income VS Free CF VS DividendAMR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 500M 1B
AMR Dividend Payout.AMR Dividend Payout, showing the Payout Ratio.AMR Dividend Payout.PayoutRetained Earnings

ALPHA METALLURGICAL RESOURCE

NYSE:AMR (8/26/2025, 8:14:52 PM)

Premarket: 145 +0.06 (+0.04%)

144.94

+0.36 (+0.25%)

Chartmill FA Rating
GICS SectorMaterials
GICS IndustryGroupMaterials
GICS IndustryMetals & Mining
Earnings (Last)08-08 2025-08-08/bmo
Earnings (Next)10-30 2025-10-30/bmo
Inst Owners85.65%
Inst Owner Change3.15%
Ins Owners5.23%
Ins Owner Change-1.65%
Market Cap1.89B
Analysts74.29
Price Target170.85 (17.88%)
Short Float %13.36%
Short Ratio3.73
Dividend
Industry RankSector Rank
Dividend Yield 0.73%
Yearly Dividend0.24
Dividend Growth(5Y)N/A
DP1.85%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-70.93%
Min EPS beat(2)-142.85%
Max EPS beat(2)0.99%
EPS beat(4)1
Avg EPS beat(4)-57.94%
Min EPS beat(4)-142.85%
Max EPS beat(4)0.99%
EPS beat(8)3
Avg EPS beat(8)-25.59%
EPS beat(12)4
Avg EPS beat(12)-18.12%
EPS beat(16)7
Avg EPS beat(16)-13.85%
Revenue beat(2)0
Avg Revenue beat(2)-7.62%
Min Revenue beat(2)-8.11%
Max Revenue beat(2)-7.14%
Revenue beat(4)1
Avg Revenue beat(4)-2.6%
Min Revenue beat(4)-8.11%
Max Revenue beat(4)8.59%
Revenue beat(8)4
Avg Revenue beat(8)1.33%
Revenue beat(12)6
Avg Revenue beat(12)1.06%
Revenue beat(16)10
Avg Revenue beat(16)4.38%
PT rev (1m)15.12%
PT rev (3m)-8.47%
EPS NQ rev (1m)-9.79%
EPS NQ rev (3m)-16.08%
EPS NY rev (1m)-54.87%
EPS NY rev (3m)-141.41%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)-0.54%
Revenue NY rev (1m)-0.61%
Revenue NY rev (3m)-9.5%
Valuation
Industry RankSector Rank
PE N/A
Fwd PE 7.06
P/S 0.72
P/FCF 8.14
P/OCF 4.66
P/B 1.17
P/tB 1.2
EV/EBITDA 6.54
EPS(TTM)-2.85
EYN/A
EPS(NY)20.54
Fwd EY14.17%
FCF(TTM)17.8
FCFY12.28%
OCF(TTM)31.11
OCFY21.47%
SpS201.16
BVpS123.74
TBVpS120.79
PEG (NY)N/A
PEG (5Y)N/A
Profitability
Industry RankSector Rank
ROA 1.11%
ROE 1.65%
ROCE 2.14%
ROIC 1.87%
ROICexc 2.36%
ROICexgc 2.41%
OM 1.74%
PM (TTM) 1.01%
GM 12.09%
FCFM 8.85%
ROA(3y)33.45%
ROA(5y)17.86%
ROE(3y)52.85%
ROE(5y)-2.4%
ROIC(3y)39.19%
ROIC(5y)N/A
ROICexc(3y)48.89%
ROICexc(5y)N/A
ROICexgc(3y)50.91%
ROICexgc(5y)N/A
ROCE(3y)44.94%
ROCE(5y)N/A
ROICexcg growth 3Y-20%
ROICexcg growth 5Y64.08%
ROICexc growth 3Y-19.44%
ROICexc growth 5Y65.48%
OM growth 3Y-22.8%
OM growth 5Y51.85%
PM growth 3Y-20.84%
PM growth 5YN/A
GM growth 3Y-12.72%
GM growth 5Y0.52%
F-Score6
Asset Turnover1.09
Health
Industry RankSector Rank
Debt/Equity 0
Debt/FCF 0.02
Debt/EBITDA 0.01
Cap/Depr 98.93%
Cap/Sales 6.62%
Interest Coverage 250
Cash Conversion 183.42%
Profit Quality 872.27%
Current Ratio 3.87
Quick Ratio 3.14
Altman-Z 4.21
F-Score6
WACC10.14%
ROIC/WACC0.18
Cap/Depr(3y)137.43%
Cap/Depr(5y)115.04%
Cap/Sales(3y)5.93%
Cap/Sales(5y)6.47%
Profit Quality(3y)126.06%
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-108.43%
EPS 3Y-1.85%
EPS 5YN/A
EPS Q2Q%-108.46%
EPS Next Y-130.1%
EPS Next 2Y20.22%
EPS Next 3Y-1.42%
EPS Next 5Y-1.55%
Revenue 1Y (TTM)-14.81%
Revenue growth 3Y9.4%
Revenue growth 5Y8.12%
Sales Q2Q%-31.56%
Revenue Next Year-24.17%
Revenue Next 2Y-3.7%
Revenue Next 3Y-2.95%
Revenue Next 5Y-1.61%
EBIT growth 1Y-93.37%
EBIT growth 3Y-15.54%
EBIT growth 5Y64.18%
EBIT Next Year-33.95%
EBIT Next 3Y27.1%
EBIT Next 5Y31.75%
FCF growth 1Y-79.16%
FCF growth 3Y60.83%
FCF growth 5YN/A
OCF growth 1Y-69.36%
OCF growth 3Y49.12%
OCF growth 5Y34.47%